A review of hereditary breast cancer: From screening to risk factor modification

American Journal of Medicine

Volumn 102, Issue 4, 1997, Pages 407-415

  Warmuth, Marc A ^a   Sutton, Linda M ^a   Winer, Eric P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ABORTION; ALCOHOL CONSUMPTION; BREAST CANCER; BREAST FEEDING; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CHEMOPROPHYLAXIS; DIET; EXERCISE; FAMILIAL CANCER; GENE MUTATION; GENETIC SCREENING; HUMAN; LACTATION; MASTECTOMY; OVARIECTOMY; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT;

BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENETIC SCREENING; HUMANS; MUTATION; NEOPLASM PROTEINS; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 0030926762     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00093-4     Document Type: Review

References (83)

1. Garber JE, Henderson IC, Love SM, Gelman RS. Management of high-risk groups. Harris JR, Hellman S, Henderson IC, Kinne DW. Breast Diseases. 2nd ed. 1991;152-163 JB Lippincott, Philadelphia.
2. Feuer EJ, Lap-Ming W, Boring CC, et al. The lifetime risk of developing breast cancer. J Natl Cancer Inst. 85:1993;892-897.
3. Miki Y, Swenson J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-71.
4. Futreal A, Liu Q, Shattuck-Eidens D, et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science. 266:1994;120-122.
5. Arason A, Barkardottir RB, Egilsson V. Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostate cancer. Am J Hum Genet. 52:1993;711-717.
6. Ford D, Easton DF, Bishop DT, et al. Risk of cancer in BRCA1-mutation carriers. Lancet. 343:1994;692-695.
7. Easton DF, Bishop DT, Ford D, et al. Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am J Hum Genet. 52:1993;678-701.
8. Easton DF, Ford D, Bishop DT. Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet. 56:1995;265-271.
9. Strewing JP, Abeliovich D, Peretz T, et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet. 11:1995;198-200.
10. Collins FS. BRCA1-Lots of mutations, lots of dilemmas. NEJM. 334:1996;186-188.
11. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 378:1995;789-792.
12. Malkin D, Le FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 250:1990;1233.
13. Swift M, Reitnauer PJ, Morrell D, Chase CL. Breast and other cancers in families with ataxia-telangiectasia. NEJM. 316:1987;1289-1294.
14. Shattuck-Eidens D, McClure M, Simard J, et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. JAMA. 273:1995;535-541.
15. Lerman C, Croyle R. Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med. 154:1994;609-616.
16. Lerman C, Narod S, Schulman K, et al. BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes. JAMA. 275:1996;1885-1892.
17. Severin MJ. Hereditary cancer litigation: a status report. Oncology. 10:1996;211-214.
18. Hawley W, Nuovo J, DeNeef CP, Carter P. Do oral contraceptive agents effect the risk of breast cancer? A meta-analysis of the case-control reports. J Am Board Fam Pract. 6:1993;123-135.
19. Rushton L, Jones DR. Oral contraceptive use and breast cancer risk: a meta-analysis of variations with age at diagnosis, parity, and total duration of oral contraceptive use. Br J Obstet Gynaecol. 99:1992;239-246.
20. Schlesselman JJ. Net effect of oral contraceptive use on the risk of cancer in women in the United States. Obstet Gynecol. 85:1995;793-801.
21. Romieu I, Willett WC, Colditz GA, et al. Prospective study of oral contraceptive use and risk of breast cancer in women. J Natl Cancer Inst. 81:1989;1313-1321.
22. Colditz GA. Oral contraceptive use and mortality during 12 years of follow-up: The Nurses' Health Study. Ann Intern Med. 120:1994;821-826.
23. Murray PP, Stadel BV, Schlesselman JJ. Oral contraceptive use in women with a family history of breast cancer. Obstet Gynecol. 73:1989;977-983.
24. Armstrong BK. Estrogen therapy after the menopause-boon or bane? Med J Aust. 148:1988;213-214.
25. Steinberg KK, Thacker SB, Smith SJ, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA. 265:1991;1985-1990.
26. Dupont WD, Page DL. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med. 151:1991;67-72.
27. Sillero-Arenas M, Delgado-Rodriguez M, Rodigues-Canteras R, et al. Menopausal hormone replacement therapy and breast cancer: a meta-analysis. Obstet Gynecol. 79:1992;286-294.
28. Colditz GA, Egan KM, Stampfer MJ. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am J Ob Gyn. 168:1993;1473-1480.
29. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. NEJM. 332:1995;1589-1593.
30. Junshi C, Campbell TC, Junyao L, et al. Diet, Life-style, and Mortality in China. 1990;Oxford University Press, Oxford.
31. Willet WC, Stampfer MJ, Colditz GA, et al. Dietary fat and the risk of breast cancer. NEJM. 316:1987;22-28.
32. Hunter DJ, Spiegelman D, Adami HO, et al. Cohort studies of fat intake and the risk of breast cancer-A pooled analysis. NEJM. 334:1996;356-361.
33. Willett WC, Stampfer MJ, Colditz GA, et al. Moderate alcohol consumption and the risk of breast cancer. NEJM. 316:1987;1174-1180.
34. Schatzkin A, Jones DY, Hoover RN, et al. Alcohol consumption and breast cancer in the epidemiologic follow-up study of the first National Health and Nutrition Examination Survey. NEJM. 316:1987;1169-1173.
35. Van den Brandt PA, Goldbohm RA, Van't Veer P. Alcohol and breast cancer: results from The Netherlands Cohort Study. Am J Epidem. 141:1995;907-915.
36. Longnecker MP, Berlin JA, Orza MJ, Chalmers TC. A meta-analysis of alcohol consumption in relation to risk of breast cancer. JAMA. 260:1988;652-656.
37. Longnecker MP. Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control. 5:1994;73-82.
38. Schatzkin A, Carter CI, Green SB, et al. Is alcohol consumption related to breast cancer? Results from the Framingham Heart Study. J Natl Cancer Inst. 81:1989;31-35.
39. Frisch RE, Wyshak G, Albright NL, et al. Lower lifetime occurrence of breast cancer and cancer of the reproductive system among former college athletes. Am J Clin Nutr. 45:1987;328-335.
40. Friedenreich CM, Rohan TE. Physical activity and risk of breast cancer. Europ J Cancer Prev. 4:1995;145-151.
41. Bernstein L, Henderson BE, Hanisch R, et al. Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst. 86:1994;1403-1408.
42. Dorgan JF, Brown C, Barrett M, et al. Physical activity and risk of breast cancer in the Framingham Heart Study. Am J Epidemiol. 139:1994;662-669.
43. Lambe M, Hsieh C, Trichopoulos D, et al. Transient increase in the risk of breast cancer after giving birth. NEJM. 331:1994;5-9.
44. Leon DA, Carpenter LM, Broeders MJ, et al. Breast cancer in Swedish women before age 50: evidence of a dual effect of completed pregnancy. Cancer Causes Control. 6:1995;283-291.
45. Vatten LJ, Kvinnsland S. Pregnancy-related factors and risk of breast cancer in a prospective study of 29,981 Norwegian women. Eur J Cancer. 28A:1992;1148-1153.
46. Albrektsen G, Heuch I, Kvale G. The short-term and long-term effect of a pregnancy on breast cancer risk: a prospective study of 802,457 parous Norwegian women. Br J Cancer. 72:1995;744-751.
47. Hadjimichael OC, Boyle CA, Meigs JW. Abortion before first live birth and risk of breast cancer. Br J Cancer. 53:1986;281-284.
48. Pike MC, Henderson BE, Casagrande JT, et al. Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer. 43:1981;72-76.
49. Rosenberg L, Palmer JR, Kaufman DW, et al. Breast cancer in relation to the occurrence and time of induced and spontaneous abortion. Am J Epidemiol. 127:1988;981-989.
50. Brinton LA, Hoover R, Fraumeni JF Jr. Reproductive factors in the aetiology of breast cancer. Br J Cancer. 47:1983;757-762.
51. Vessey MP, McPherson K, Yeates D, Doll R. Oral contraceptive use and abortion before first term pregnancy in relation to breast cancer risk. Br J Cancer. 45:1982;327-331.
52. Paffenbarger R Jr, Kampert JB, Chang H. Characteristics that predict risk of breast cancer before and after the menopause. Am J Epidem. 112:1980;258-268.
53. Andrieu N, Duffy SW, Rohan TE, et al. Familial risk, abortion and their interactive effect on the risk of breast cancer - a combined analysis of six case-control studies. Br J Cancer. 72:1995;744-751.
54. Kvale G, Heuch I, Eide GE. A prospective study of reproductive factors and breast cancer I. Parity. Am J Epidemiol. 126:1987;831-841.
55. McTiernan, Thomas DB. Evidence for a protective effect of lactation on risk of breast cancer in young women: Results from a case-control study. Am J Epidem. 124:1986;353-358.
56. Layde PM, Webster LA, Baughman AL. The independent associations of parity, age at first full term pregnancy, and duration of breast feeding with the risk of breast cancer. J Clin Epidemiol. 42:1989;963-967.
57. Siskind V, Schofield F, Rice D, Bain C. Breast cancer and breastfeeding: results from an Australian case-control study. J Clin Epidemiol. 130:1989;229-236.
58. Kvale G, Heuch I. Lactation and cancer risk: is there a relation specific to breast cancer? J Epidemiol Community Health. 42:1988;30-37.
59. London SJ, Colditz GA, Stampfer MJ, et al. Lactation and risk of breast cancer in a cohort of US women. Am J Epidemiol. 132:1990;17-26.
60. Newcomb PA, Storer BE, Longnecker MP, et al. Lactation and a reduced risk of premenopausal breast cancer. NEJM. 220:1994;81-87.
61. Mettlin C, Smart CR. Breast cancer detection guidelines for women aged 40 to 49 years: Rationale for the American Cancer Society reaffirmation of recommendations. CA Cancer J Clin. 44:1994;248-255.
62. Fletcher SW, Black W, Harris R, et al. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst. 85:1993;1644-1656.
63. Dodd GD. American Cancer Society guidelines on screening for breast cancer: an overview. Cancer. 42:1992;177-180.
64. Guide to Clinical Preventive Services. 1989;US Department of Health and Human Services, Washington, DC.
65. Lesnick GJ. Detection of breast cancer in young women. JAMA. 237:1977;967-969.
66. Meyer JE, Kopans DB, Oot R. Breast cancer visualized by mammography in patients under 35. Radiology. 147:1983;93-94.
67. Morrow M. Identification and management of women at increased risk for breast cancer development. Breast Cancer Res Treat. 31:1994;53-60.
68. Cohen MI, Mintzer R, Matthies HJ, Berntein JR. Mammography in women less than 40 years of age. Surg Gynecol Obstet. 160:1985;220-222.
69. McSweeney MB, Egan RL. Breast cancer, not just a disease of middle age. Diagnostic Imaging. 1:1984;48-49.
70. Foster RS Jr, Lang SP, Costanza MC, et al. Breast self-examination practices and breast-cancer stage. NEJM. 299:1978;265-270.
71. Greenwald P, Nasca PC, Lawrence CE, et al. Estimated effect of breast self-examination and routine physician examinations on breast-cancer mortality. NEJM. 299:1978;271-273.
72. Laughter DC, Kean TJ, Dream KD, et al. The breast self-examination practices of high risk women: Implications for patient education. Patient Couns Health Educ. 3:1981;103-107.
73. Shapiro S, Venet W, Strax P, Venet L. Periodic screening for breast cancer. The Health Insurance Plan Project and its sequelae, 1963-1986. 1988;Johns Hopkins University Press, Baltimore.
74. Houn F, Helzlsouer KJ, Friedman NB, Stefanek ME. The practice of prophylactic mastectomy: A survey of Maryland surgeons. Am J Public Health. 85:1995;801-805.
75. Goodnight JE Jr, Quagliana JM, Morton DL. Failure of subcutaneous mastectomy to prevent the development of breast cancer. J Surg Oncol. 26:1984;198-201.
76. Temple WJ, Lindsay RL, Magi E, Urbanski SJ. Technical considerations for prophylactic mastectomy in patients at high risk for breast cancer. Am J Surg. 161:1991;413-415.
77. Wong JH, Jackson CF, Swanson JS, et al. Analysis of the risk reduction of prophylactic partial mastectomy in Sprague-Dawley rats with 7,12 dimethylbenzathracene-induced breast cancer. Surgery. 99:1986;67-71.
78. Nelson H, Miller SH, Buck D, et al. Effectiveness of prophylactic mastectomy in the prevention of breast tumors in C3H mice. Plast Reconstr Surg. 83:1989;662-669.
79. Holleb AI, Montogomery R, Farrow JH. The hazard of incomplete simple mastectomy. Surg Gynecol Obstet. 121:1965;819-827.
80. Ovarian Cancer: Screening, treatment, and follow-up. JAMA. 273:1995;491-497.
81. Muto MG, Cramer DW, Brown DL, et al. Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center. Gynecol Onol. 51:1993;12-20.
82. Piver MS, Jishi MF, Tsukada Y, Nava G. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry. Cancer. 71:1993;2751-2755.
83. Tobacman JK, Greene MH, Tucker MA, et al. Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families. Lancet. 2:1982;795-797.